Advertisement
Advertisement
U.S. Markets open in 8 hrs 53 mins
Advertisement
Advertisement
Advertisement
Advertisement

Anavex Life Sciences Corp. (AVXL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
17.91-1.49 (-7.68%)
At close: 04:00PM EST
17.80 -0.11 (-0.61%)
After hours: 07:57PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 12/2/2021
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.70
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 331.50
52 Week Low 34.51
50-Day Moving Average 319.18
200-Day Moving Average 317.21

Share Statistics

Avg Vol (3 month) 3806.12k
Avg Vol (10 day) 31.05M
Shares Outstanding 570.04M
Implied Shares Outstanding 6N/A
Float 867.77M
% Held by Insiders 13.36%
% Held by Institutions 126.04%
Shares Short (Jul 14, 2021) 47.6M
Short Ratio (Jul 14, 2021) 41.66
Short % of Float (Jul 14, 2021) 410.86%
Short % of Shares Outstanding (Jul 14, 2021) 410.50%
Shares Short (prior month Jun 14, 2021) 47.02M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Oct 06, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 29, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-31.66%
Return on Equity (ttm)-56.58%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-28.46M
Diluted EPS (ttm)-0.45
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)75.86M
Total Cash Per Share (mrq)1.08
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)10.76
Book Value Per Share (mrq)1.08

Cash Flow Statement

Operating Cash Flow (ttm)-25.49M
Levered Free Cash Flow (ttm)-15.16M
Advertisement
Advertisement